Abstract
Epidemiology has been transformed by the advent of Bayesian phylodynamic models that allow researchers to infer the geographic history of pathogen dispersal over a set of discrete geographic areas (1, 2). These models provide powerful tools for understanding the spatial dynamics of disease outbreaks, but contain many parameters that are inferred from minimal geographic information (i.e., the single area in which each pathogen was sampled). Consequently, inferences under these models are inherently sensitive to our prior assumptions about the model parameters. Here, we demonstrate that the default priors used in empirical phylodynamic studies make strong and biologically unrealistic assumptions about the underlying geographic process. We provide empirical evidence that these unrealistic priors strongly (and adversely) impact commonly reported aspects of epidemiological studies, including: (1) the relative rates of dispersal between areas; (2) the importance of dispersal routes for the spread of pathogens among areas; (3) the number of dispersal events between areas, and; (4) the ancestral area in which a given outbreak originated. We offer strategies to avoid these problems, and develop tools to help researchers specify more biologically reasonable prior models that will realize the full potential of phylodynamic methods to elucidate pathogen biology and, ultimately, inform surveillance and monitoring policies to mitigate the impacts of disease outbreaks.
Significance Statement Bayesian phylodynamic models have revolutionized epidemiology by enabling researchers to infer key aspects of the geographic history of disease outbreaks. These models contain many parameters that must be estimated from minimal information (the area from which each pathogen was sampled), rendering inferences under this approach inherently sensitive to the choice of priors on the model parameters. Here, we demonstrate that: (1) the priors assumed in ≈93% of surveyed phylodynamic studies make strong and biologically unrealistic assumptions, and; (2) these priors distort the conclusions of epidemiological studies. We offer strategies and tools to specify more reasonable priors that will enhance our ability to understand pathogen biology and, thereby, to mitigate disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the National Science Foundation grants DEB-0842181, DEB-0919529, DBI-1356737, and DEB-1457835 awarded to BRM, and the National Institutes of Health grant RO1GM123306-S awarded to BR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.